Strategies for the discovery of cytokine receptor antagonists

Drug News and Perspectives

Volumn 9, Issue 7, 1996, Pages 389-398

  McKinnon, M ^a   Proudfoot, A E I ^a   Wells, T N C ^a   Solari, R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; INTERFERON BETA SERINE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT BETA INTERFERON; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 2; RECOMBINANT PROTEIN; TACROLIMUS; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL MODEL; ASTHMA; CANCER; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG INDICATION; HUMAN; INFLAMMATION; NEUTROPENIA; NONHUMAN; PHARMACEUTICS; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0029786197     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)